PVLA
Palvella TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
PVLA vs peer average
55/100
PVLA vs. peer average (C vs. C)
Grade spread
A 2 · B 1 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
NTLA is the first available peer comparator.
Event-driven biotech comparator for how single major regulatory or clinical milestones can dominate market value, though modality and target markets differ materially.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PVLA
Palvella Therapeutics
NTLA
Intellia Therapeutics
Grade
C
D
Momentum
51
17
Value
41
41
Sentiment
70
65
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs NTLA
PVLA / NTLA
Grade Position
In line
PVLA vs. peer average (C vs. C)
55/100
Momentum
51
PVLAValue
41
PVLASentiment
70
PVLARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PVLA
NTLA is the first peer returned for this comparison set.